Please note, throughout this website, when discussing “SMA”, we are referring to 5q SMA, the most common form of the disease.
Relevance and implications of real-world data on the use of Spinraza® 
(nusinersen) in adults with 5q SMA, and sharing UK experience
Adult Data Webinar
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.
Healthcare professionals are asked to report any suspected adverse reactions.
Adverse events should be reported. For Ireland, reporting forms and information can be found at www.hpra.ie. For the UK, reporting forms and information can be found at yellowcard.mhra.gov.uk or via the Yellow Card app available from the Apple App Store or Google Play Store. Adverse events should also be reported to Biogen Idec Ltd on 1800 812 719 in Ireland and 0800 008 7401 in the UK.
Biogen-75739 Date of preparation: February 2021